Hidefumi Hiramatsu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Rheumatoid Arthritis Patients

Acute Lymphoblastic Leukemia

Top Venues

Molecules and cells

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kiyotaka Isobe, Satoshi Saida, Yoshitaka Honda, Hiroshi Nihira, Eitaro Hiejima, Kazushi Izawa, Hirohito Kubota, Itaru Kato, Katsutsugu Umeda, Hidefumi Hiramatsu, Takahiro Yasumi, Junko Takita
Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency. Pediatric blood & cancer 71 (8) (2024)
Kiyotaka Isobe, Satoshi Saida, Yoshitaka Honda, Hiroshi Nihira, Eitaro Hiejima, Kazushi Izawa, Hirohito Kubota, Itaru Kato, Katsutsugu Umeda, Hidefumi Hiramatsu, Takahiro Yasumi, Junko Takita
Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency. Pediatric blood & cancer (2024)
Kiyotaka Isobe, Satoshi Saida, Yoshitaka Honda, Hiroshi Nihira, Eitaro Hiejima, Kazushi Izawa, Hirohito Kubota, Itaru Kato, Katsutsugu Umeda, Hidefumi Hiramatsu, Takahiro Yasumi, Junko Takita
Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency. Pediatric blood & cancer 71 (8) (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances 8 (5) (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances 8 (5) (2024)
Masanori Yoshida, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Daisuke Hasegawa, Hiroshi Mirotaki, Daiichiro Hasegawa, Kiminori Terui, Asahito Hama, Shin-Ichi Tsujimoto, Nobutaka Kiyokawa, Hayato Miyachi, Takao Deguchi, Yoshiko Hashii, Yuka Iijima-Yamashita, Tomohiko Taki, Yasushi Noguchi, Kazutoshi Koike, Katsuyoshi Koh, Yuki Yuza, Akiko M Saito, Keizo Horibe, Takashi Taga, Shiro Tanaka, Souichi Adachi
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia. Leukemia (2023)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances (2023)
Hidefumi Hiramatsu
Current status of CAR-T cell therapy for pediatric hematologic malignancies. International journal of clinical oncology (2023)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Koji Nakajima, Hirohito Kubota, Itaru Kato, Kiyotaka Isobe, Hiroo Ueno, Kagehiro Kozuki, Kuniaki Tanaka, Naoko Kawabata, Takashi Mikami, Kosuke Tamefusa, Ritsuo Nishiuchi, Satoshi Saida, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi, Junko Takita
PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch. Cancer science 113 (7) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Naoko Kawabata, Hidefumi Hiramatsu, Takashi Mikami, Ryo Akazawa, Kuniaki Tanaka, Kagehiro Kouzuki, Hirohito Kubota, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Tomoaki Hirate, Kaori Kanda, Souichi Adachi, Junko Takita
Chimeric antigen receptor T-cell therapy for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia and leukoencephalopathy who relapsed after bone marrow transplantation. Pediatric blood & cancer 69 (11) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Theodore W Laetsch, Shannon L Maude, Adriana Cristina Balduzzi, Susana Rives, Henrique Bittencourt, Michael W Boyer, Jochen Buechner, Barbara De Moerloose, Muna Qayed, Christine L Phillips, Michael A Pulsipher, Hidefumi Hiramatsu, Ranjan Tiwari, Stephan A Grupp
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia. Leukemia 36 (6) (2022)
Makiko Morita, Yasuyuki Arai, Takashi Ishihara, Tomoko Onishi, Hanako Shimo, Kayoko Nakanishi, Yukiko Nishiyama, Tomoyasu Jo, Hidefumi Hiramatsu, Takaya Mitsuyoshi, Chisaki Mizumoto, Junya Kanda, Momoko Nishikori, Toshio Kitawaki, Keiji Nogami, Akifumi Takaori-Kondo, Miki Nagao, Souichi Adachi
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma. Blood advances 6 (14) (2022)
Satoshi Obu, Katsutsugu Umeda, Hiroo Ueno, Mari Sonoda, Keiji Tasaka, Hideto Ogata, Kagehiro Kouzuki, Seishiro Nodomi, Satoshi Saida, Itaru Kato, Hidefumi Hiramatsu, Tatsuya Okamoto, Eri Ogawa, Hideaki Okajima, Ken Morita, Yasuhiko Kamikubo, Koji Kawaguchi, Kenichiro Watanabe, Hideto Iwafuchi, Shigeki Yagyu, Tomoko Iehara, Hajime Hosoi, Tatsutoshi Nakahata, Souichi Adachi, Shinji Uemoto, Toshio Kitawaki, Junko Takita
CD146 is a potential immunotarget for neuroblastoma. Cancer science 112 (11) (2021)
Michael A Pulsipher, Xia Han, Shannon L Maude, Theodore W Laetsch, Muna Qayed, Susana Rives, Michael W Boyer, Hidefumi Hiramatsu, Gregory A Yanik, Tim Driscoll, G Doug Myers, Peter Bader, Andre Baruchel, Jochen Buechner, Heather E Stefanski, Creton Kalfoglou, Kevin Nguyen, Edward R Waldron, Karen Thudium Mueller, Harald J Maier, Gabor Kari, Stephan A Grupp
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia. Blood cancer discovery 3 (1) (2021)
Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki, Shotaro Iwamoto, Hidefumi Hiramatsu, Takako Miyamura, Yoshiko Hashii, Hiroshi Mirotaki, Hideki Nakayama, Hiroyuki Takahashi, Akira Shimada, Tomohiko Taki, Etsuro Ito, Asahito Hama, Masafumi Ito, Katsuyoshi Koh, Daiichiro Hasegawa, Akiko M Saito, Souichi Adachi, Masanori Yoshida
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome. Leukemia 35 (9) (2021)
Hidefumi Hiramatsu, Souichi Adachi, Katsutsugu Umeda, Itaru Kato, Lamis Eldjerou, Andrea Chassot Agostinho, Kazuto Natsume, Kota Tokushige, Yoko Watanabe, Stephan A Grupp
Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia. International journal of hematology 111 (2) (2019)